[Study on the effect of antirheumatic therapy on the indices of the leukocyte migration inhibition test using myocardial cell membrane antigens in patients with rheumatism].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000941:Antigens; D001241:Aspirin / Q000627:therapeutic use; D002462:Cell Membrane / Q000276:immunology; D002464:Cell Migration Inhibition; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000276:immunology*; D011720:Pyrazoles / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000276:immunology*; D012213:Rheumatic Fever / Q000276:immunology; D012214:Rheumatic Heart Disease / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000941:Antigens; D006728:Hormones; D011720:Pyrazoles; D001241:Aspirin
Izuchenie vliianiia antirevmaticheskoĭ terapii na pokazateli RTML s ispol'zovaniem antigenov kletochnykh membran miokarda u bol'nykh revmatizmom.